Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) and Oxidative DNA Damage in Children With Simple and Complex Febrile Seizures: An Exploratory Prospective Case-Control Study

NCT07660003 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.

NCT NCT07660003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07660003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) and Oxidative DNA Damage in Children With Simple and Complex Febrile Seizures: An Exploratory Prospective Case-Control Study
Lead sponsor
Kayseri City Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2021
Completion date
December 30, 2022
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

febrile seizures, oxidative dna damage, oxidative stress